Almost two years ago, in March 2020, I published the post below on Medium. At that time, we were at the earliest stages of the...

Three studies report promising results in the use of cutting-edge genome editing and cellular therapies for hard-to-treat blood disorders and cancers.

Outside the pandemic, “investigational” remains payer code for denying reimbursement. In the case of treatment for chronic conditions, even FDA-approved digital-health and connected devices languish on waitlists for formulary inclusion.

Dallas’ own Match Group announced a public health partnership with the Biden White House to help promote Covid-19 vaccination across its portfolio of dating apps